SCHEMBL31514944

SCHEMBL31514944

CCN(CCCCN(C)C(=O)CCCNC(=O)OC(C)(C)C)C(=O)c1ccc2c([N+](=O)[O-])c(O)c(O)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ COMT P21964 1/20 0.42
▸ CCNC P24863 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ CA1 P00915 8/20 0.34
▸ CA2 P00918 8/20 0.34
▸ MC4R P32245 1/20 0.33
▸ PDK1 Q15118 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ PDK3 Q15120 1/20 0.33
▸ PDK4 Q16654 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ BCHE P06276 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ NQO2 P16083 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ PARP1 P09874 1/20 0.31
▸ CA12 O43570 4/20 0.31
▸ CA9 Q16790 4/20 0.31
▸ THRA P10827 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31514933 1.00 COMT (0.42) COMTCCNCCDK8CA1CA2
SCHEMBL31514946 0.91 COMT (0.47) COMTCCNCCDK8CA1CA2
SCHEMBL31514934 0.91 COMT (0.47) COMTCCNCCDK8CA1CA2
SCHEMBL29642781 0.89 COMT (0.58) COMTCA1CA2BCHEACHE
SCHEMBL20590973 0.89 COMT (0.58) COMTCA1CA2BCHEACHE
SCHEMBL31514940 0.86 COMT (0.50) COMTHSP90AA1HSP90AB1BCHEACHE
SCHEMBL31514939 0.86 COMT (0.50) COMTHSP90AA1HSP90AB1BCHEACHE
SCHEMBL31514937 0.85 COMT (0.49) COMTHSP90AA1HSP90AB1BCHEACHE
SCHEMBL19015270 0.79 COMT (0.66) COMTCA1CA2NQO2BRD4
SCHEMBL29642848 0.79 COMT (0.66) COMTCA1CA2NQO2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390351-B1 NOVEL BICYCLIC-COMPOUNDS FOR USE AS A MEDICAMENT, IN PARTICULAR FOR TREATMENT OF PARKINSON'S DISEASE KOESTER HUBERT (DE) 2025-02-26 — — EP claimed
Send feedback